Gapping up
In reaction to strong earnings/guidance:
- CMC +7.4%, PERI +6.7% (guidance)
Select metals/mining stocks trading higher:
- DRD +9.3%, MTL +8.5%, HMY +5.6%, SBGL +4.8%, AU +4.2%, GFI +4.1%, AG +3.8%, AUY +3.6%, IAG +3%, KGC +2.8%, PAAS +2.6%, NEM +2.5%, GDX +2.3%, SLV +2.2%, GOLD +2%, GLD +1.8%
Select oil/gas related names showing strength:
- DNR +8.4%, NBR +2.2%, TOT +2.1%, RDS.A +1.3%, MRO +1.2%, RIG +1.1%, HAL +0.8%, SLB +0.6%
Other news:
- NIO +10.7% (delivered 3,170 vehicles in December 2019 or +25.4% mo/mo)
- XON +4.2% (FDA has granted orphan drug designation to PRGN-3006)
- ELAN +0.7% (signed an agreement to divest Osurnia, a treatment for otitis externa in dogs, to Dechra Pharmaceuticals for $135 mln in an all-cash deal)
- HOOK +0.6% (progress in its collaboration with Gilead for novel arenavirus-based therapeutics intended to support functional cures for chronic HBV and HIV infections)
- MYGN +0.6% (demonstrates GeneSight improved all clinical outcomes using HAM-D6 analysis in large prospective guided study)
Analyst comments:
- EQH +0.7% (upgraded to Overweight from Equal Weight at Wells Fargo)
- FITB +0.5% (upgraded to Overweight from Equal Weight at Barclays)